Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Dec 2025. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5504608015 | Vanzacaftor calcium (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5504609011 | Vanzacaftor calcium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vanzacaftor calcium (substance) | Is a | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action (substance) | true | Inferred relationship | Some | ||
| Vanzacaftor calcium (substance) | Has disposition (attribute) | Cystic fibrosis transmembrane conductance regulator potentiator (disposition) | true | Inferred relationship | Some | ||
| Vanzacaftor calcium (substance) | Is modification of (attribute) | Vanzacaftor | true | Inferred relationship | Some | ||
| Vanzacaftor calcium (substance) | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Vanzacaftor calcium (substance) | Is a | Respiratory system agent (substance) | true | Inferred relationship | Some | ||
| Vanzacaftor calcium (substance) | Is a | Polycyclic compound (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vanzacaftor calcium dihydrate | Is modification of (attribute) | True | Vanzacaftor calcium (substance) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR